Structures by: Wang L. L.
Total: 39
C38H42BrN5O3,2(CH4O)
C38H42BrN5O3,2(CH4O)
Chemical Science (2020) 11, 5 1418-1424
a=11.9227(3)Å b=17.3502(4)Å c=17.7857(4)Å
α=90° β=90.6110(10)° γ=90°
C29H27ClN2O
C29H27ClN2O
Chemical Science (2020) 11, 5 1418-1424
a=10.8554(2)Å b=18.2505(2)Å c=12.2873(2)Å
α=90° β=105.0100(10)° γ=90°
C46H42BrN3O
C46H42BrN3O
Chemical Science (2020) 11, 5 1418-1424
a=10.2078(3)Å b=19.1520(5)Å c=18.9514(4)Å
α=90° β=94.804(2)° γ=90°
C28H29N3O
C28H29N3O
Chemical Science (2020) 11, 5 1418-1424
a=9.0448(4)Å b=14.0503(6)Å c=18.8685(6)Å
α=90° β=102.053(4)° γ=90°
C31H31BrN2O
C31H31BrN2O
Chemical Science (2020) 11, 5 1418-1424
a=14.4850(5)Å b=10.8239(5)Å c=16.4134(7)Å
α=90° β=90.869(3)° γ=90°
C39H39N5O5
C39H39N5O5
Chemical Science (2020) 11, 5 1418-1424
a=11.80408(14)Å b=18.74504(18)Å c=31.2581(4)Å
α=90° β=79.1361(11)° γ=90°
C45H39Cl2N3O
C45H39Cl2N3O
Chemical Science (2020) 11, 5 1418-1424
a=13.58053(11)Å b=20.7753(2)Å c=29.2921(3)Å
α=90° β=102.8973(9)° γ=90°
5-Fluorouracil Caffeic Acid
C4H3FN2O2?C9H8O4?2(H2O)
CrystEngComm (2020) 22, 45 7992-8006
a=6.9299(11)Å b=6.9584(10)Å c=15.946(2)Å
α=99.753(5)° β=96.384(5)° γ=98.812(5)°
5-fluorouracil L-phenylalanine
C4H3FN2O2,C9H11NO2
CrystEngComm (2020)
a=7.00870(10)Å b=12.3981(2)Å c=15.1304(3)Å
α=90° β=90° γ=90°
C4H8NaNiO16Ru2,3(H2O)
C4H8NaNiO16Ru2,3(H2O)
Chemical communications (Cambridge, England) (2020) 56, 9 1369-1372
a=18.251(3)Å b=9.2828(16)Å c=10.1645(17)Å
α=90° β=90° γ=90°
C42H30IrN6,Cl
C42H30IrN6,Cl
Chem. Commun. (2017)
a=13.3299(5)Å b=13.6244(4)Å c=15.0507(5)Å
α=99.8240(10)° β=101.6270(10)° γ=115.7660(10)°
KMg4Sb3
KMg4Sb3
Journal of Materials Chemistry A (2018) 6, 11 4759
a=4.6642(6)Å b=15.3824(18)Å c=13.1613(16)Å
α=90° β=90° γ=90°
Cs2Mg5Sb4
Cs2Mg5Sb4
Journal of Materials Chemistry A (2018) 6, 11 4759
a=13.124(3)Å b=7.8217(16)Å c=13.235(3)Å
α=90° β=90° γ=90°
Mg5Rb2Sb4
Mg5Rb2Sb4
Journal of Materials Chemistry A (2018) 6, 11 4759
a=13.047(11)Å b=7.813(7)Å c=13.084(12)Å
α=90° β=90° γ=90°
C44H34N7Pt
C44H34N7Pt
RSC Advances (2018) 8, 20 10756
a=7.809(7)Å b=19.125(18)Å c=24.66(2)Å
α=90.00° β=90.42° γ=90.00°
C21H23N3O3S
C21H23N3O3S
Med. Chem. Commun. (2016) 7, 9 1759
a=22.120(3)Å b=11.7114(16)Å c=16.324(2)Å
α=90.00° β=109.222(4)° γ=90.00°
C40H48Mo13N8O51P4Zn
C40H48Mo13N8O51P4Zn
Dalton transactions (Cambridge, England : 2003) (2018) 47, 10 3218-3222
a=25.344(13)Å b=13.358(6)Å c=25.863(13)Å
α=90° β=112.772(7)° γ=90°
C60H83Mo19N12NaO55
C60H83Mo19N12NaO55
Dalton transactions (Cambridge, England : 2003) (2018) 47, 10 3218-3222
a=26.444(3)Å b=28.562(3)Å c=29.277(3)Å
α=90° β=90° γ=90°
C74H71Cl11N4O2P2Pt2
C74H71Cl11N4O2P2Pt2
Dalton transactions (Cambridge, England : 2003) (2018) 47, 30 10179-10186
a=17.8378(9)Å b=18.8895(8)Å c=22.3559(10)Å
α=90° β=90° γ=90°
C74H71Cl11N4O2P2Pt2
C74H71Cl11N4O2P2Pt2
Dalton transactions (Cambridge, England : 2003) (2018) 47, 30 10179-10186
a=17.8626(6)Å b=18.8915(6)Å c=22.3609(6)Å
α=90° β=90° γ=90°
C154H149Cl4N13O13P4Pt4
C154H149Cl4N13O13P4Pt4
Dalton transactions (Cambridge, England : 2003) (2018) 47, 30 10179-10186
a=14.5011(11)Å b=22.6547(17)Å c=23.2331(18)Å
α=90° β=103.3760(10)° γ=90°
H11O18P4Ru2,2(H2O)
H11O18P4Ru2,2(H2O)
Dalton transactions (Cambridge, England : 2003) (2019) 48, 23 8039-8043
a=7.4047(14)Å b=7.6292(16)Å c=7.6771(15)Å
α=94.658(3)° β=98.754(3)° γ=112.864(3)°
CuH14O22P4Ru2,2(H2O),2(K)
CuH14O22P4Ru2,2(H2O),2(K)
Dalton transactions (Cambridge, England : 2003) (2019) 48, 23 8039-8043
a=7.7337(12)Å b=8.4478(13)Å c=9.1576(14)Å
α=87.824(2)° β=76.102(2)° γ=64.533(2)°
CuH14O22P4Ru2,2(H2O),2(Rb)
CuH14O22P4Ru2,2(H2O),2(Rb)
Dalton transactions (Cambridge, England : 2003) (2019) 48, 23 8039-8043
a=7.858(2)Å b=8.425(2)Å c=9.230(3)Å
α=86.978(6)° β=75.656(5)° γ=64.585(5)°
CuH14O22P4Ru2,2(H2O),2(Cs)
CuH14O22P4Ru2,2(H2O),2(Cs)
Dalton transactions (Cambridge, England : 2003) (2019) 48, 23 8039-8043
a=8.006(4)Å b=8.475(4)Å c=9.314(5)Å
α=85.061(9)° β=74.589(8)° γ=64.129(7)°
C27H22BrNO2
C27H22BrNO2
Chemical communications (Cambridge, England) (2010) 46, 42 8064-8066
a=14.772(2)Å b=11.1689(17)Å c=13.281(2)Å
α=90.00° β=90.00° γ=90.00°
Poly[[bis(dimethylformamide)(μ~6~-4,4,4''-{[(2,4,6-trimethylbenzene-1,3,5-triyl)tris(methylene)]tris(oxy)}tribenzoato)lanthanum(III)] dimethylformamide tetrasolvate 0.25-hydrate]
C39H41LaN2O11,4(C3H7NO),0.25(H2O)
Acta Crystallographica Section C (2019) 75, 9
a=12.947(3)Å b=13.889(3)Å c=16.2890(11)Å
α=77.482(3)° β=73.859(3)° γ=85.101(2)°
N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenylsulfanyl)-2-hydroxy- 2-methylpropionamide
C18H14F4N2O2S
Acta Crystallographica Section E (2006) 62, 10 o4545-o4546
a=10.136(5)Å b=10.343(6)Å c=10.524(4)Å
α=106.82(2)° β=116.97(2)° γ=95.19(2)°
3-p-Tolylimidazo[1,2-b]pyridazine
C13H11N3
Acta Crystallographica Section E (2007) 63, 4 o1749-o1750
a=5.6240(6)Å b=10.6353(12)Å c=17.975(2)Å
α=90.00° β=94.285(2)° γ=90.00°
2,2'-dithiodibenzoic acid--1,3-di-4-pyridylpropane (1/1)
C14H10O4S2,C13H14N2
Acta Crystallographica Section C (2009) 65, 9 o492-o494
a=20.9613(13)Å b=9.3021(5)Å c=13.3790(8)Å
α=90.00° β=100.3990(10)° γ=90.00°
Aquabis(4-nitrobenzoato)-κ^2^<i>O</i>,<i>O</i>;κ<i>O</i>-(piperidinium-4- carboxylato-κ^2^<i>O</i>,<i>O</i>')cadmium(II)
C20H21CdN3O11
Acta Crystallographica Section E (2009) 65, 6 m664-m665
a=22.7135(7)Å b=6.6294(2)Å c=14.9658(5)Å
α=90.00° β=91.3400(10)° γ=90.00°
7'-Methyl-5'-oxo-2',3'-dihydrospiro[1,3-dioxolane-2,1'(5'<i>H</i>)- indolizine]-6'-carbonitrile
C12H12N2O3
Acta Crystallographica Section E (2010) 66, 9 o2431
a=7.9460(16)Å b=25.945(5)Å c=5.3430(11)Å
α=90.00° β=90.00° γ=90.00°
1,2-Bis(4-methylphenoxy)ethane
C16H18O2
Acta Crystallographica Section E (2010) 66, 11 o3000
a=27.173(5)Å b=5.5510(11)Å c=9.2780(19)Å
α=90.00° β=93.55(3)° γ=90.00°
Bis[2-bromo-4-(2-hydroxyethyl)phenol] monohydrate
2(C8H9BrO2),H2O
Acta Crystallographica Section E (2011) 67, 5 o1109
a=5.9790(12)Å b=18.396(4)Å c=16.801(3)Å
α=90.00° β=98.83(3)° γ=90.00°
1-{(<i>Z</i>)-1-(2,4-Dichlorophenyl)-1-[2-(4-methylphenoxy)ethoxy]prop- 1-en-2-yl}-1<i>H</i>-imidazol-3-ium nitrate
C21H21Cl2N2O2,NO3
Acta Crystallographica Section E (2013) 69, 1 o27
a=9.5300(19)Å b=9.924(2)Å c=12.449(3)Å
α=69.05(3)° β=80.59(3)° γ=88.75(3)°
3,4-Dihydroxyphenethyl acetate
C10H12O4
Acta Crystallographica Section E (2011) 67, 8 o1996
a=11.088(2)Å b=7.7100(15)Å c=12.687(3)Å
α=90.00° β=114.50(3)° γ=90.00°
Bis(4-aminobenzoato)-κ^2^<i>O</i>,<i>O</i>;κ<i>O</i>- (2,2'-bipyridine-κ^2^<i>N</i>,<i>N</i>')zinc
C24H20N4O4Zn
Acta Crystallographica Section E (2011) 67, 10 m1470
a=7.9499(14)Å b=10.7281(19)Å c=13.905(2)Å
α=80.499(2)° β=80.921(2)° γ=70.538(2)°
C18H22BrNO4S
C18H22BrNO4S
The Journal of organic chemistry (2012) 77, 18 8338-8343
a=7.5536(18)Å b=7.5571(18)Å c=16.888(4)Å
α=91.672(3)° β=98.728(3)° γ=102.127(3)°
C66H66N2O10,C8H8O
C66H66N2O10,C8H8O
Journal of the American Chemical Society (2017)
a=12.5032(7)Å b=16.7970(10)Å c=17.5538(10)Å
α=78.622(3)° β=82.793(3)° γ=69.513(3)°